Dialog
Dialog offers a modular, end-to-end pharmacovigilance literature monitoring solution that supports organizations tasked with drug safety reporting by streamlining and automating the entire literature triage process. It provides access to over 140 authoritative scientific and medical literature databases, such as MEDLINE, Embase, and Biosis, standardizing content across sources to ensure consistent precision search, deduplication, and structured XML output. The DialogML engine employs artificial intelligence to rank search results by patient-safety relevance, highlight key safety concepts, and tag references related to ICSRs (Individual Case Safety Reporting), aggregate reports (PBRER, PSUR, DSUR), and safety signals, so reviewers can rapidly identify high-priority articles. The Dialog Alerts Manager simplifies alert creation and management, offering bulk editing, audit trails of search strategy changes, scheduling flexibility, and delivery history tracking.
Learn more
DrugCard
DrugCard is an AI-enabled data intelligence platform designed to streamline pharmacovigilance processes by automating local literature screening. The platform supports over 100 languages and monitors more than 1,000 local medical journals across 55+ countries, ensuring continuous, regular, and transparent monitoring. By automating routine tasks, DrugCard enables Contract Research Organizations (CROs) to manage more pharmacovigilance projects and improve screening results, Marketing Authorization Holders (MAHs) to conduct in-house literature screening more effectively, and freelancers to save up to 70% of their time for other value-adding activities. The platform is designed to be scalable to new markets, cost-effective, and compliant with regulatory requirements, providing a comprehensive solution for drug safety departments.
Learn more
CoVigilAI
CoVigilAI is an AI-enabled medical literature monitoring solution that employs advanced algorithms and data analytics to proactively detect and manage adverse drug events, ensuring patient safety and regulatory compliance in real time. The platform offers streamlined tracking of scientific and medical publications across prominent global literature databases such as PubMed and Embase, with customizable search strings facilitating an effortless pharmacovigilance literature monitoring journey. Periodic surveillance of scientific and medical literature databases and publications from diverse local journals is conducted, encompassing both global literature monitoring and localized literature surveillance. Advanced algorithms categorize Individual Case Safety Reports (ICSRs) into valid, potential, and invalid cases, while automated key entity detection efficiently recognizes crucial entities like patients, medications, adverse events, and designated medical events.
Learn more
IQVIA
Thousands of organizations around the world trust IQVIA to speed drug development, ensure product quality and safety, improve commercial effectiveness, get the right treatments to patients, improve access to and delivery of healthcare, and ultimately drive better health outcomes. Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster. With a foundation in data, advanced analytics, and expert insight, IQVIA brings specialized capabilities to customers across the healthcare ecosystem. Read and watch the latest from IQVIA data scientists, doctors, researchers, and other subject matter experts on the topics that matter to you. From industry trends to how we are applying our capabilities to help, you can find it here.
Learn more